Annual Total Expenses
$143.31 M
+$30.93 M+27.52%
31 December 2023
Summary:
Monte Rosa Therapeutics annual total expenses is currently $143.31 million, with the most recent change of +$30.93 million (+27.52%) on 31 December 2023. During the last 3 years, it has risen by +$115.30 million (+411.64%). GLUE annual total expenses is now at all-time high.GLUE Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Expenses
$35.74 M
-$1.59 M-4.27%
30 September 2024
Summary:
Monte Rosa Therapeutics quarterly total expenses is currently $35.74 million, with the most recent change of -$1.59 million (-4.27%) on 30 September 2024. Over the past year, it has dropped by -$1.22 million (-3.31%). GLUE quarterly total expenses is now -4.27% below its all-time high of $37.34 million, reached on 30 June 2024.GLUE Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GLUE Total Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +27.5% | -3.3% |
| 3 y3 years | +411.6% | +79.9% |
| 5 y5 years | - | - |
GLUE Total Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +411.6% | -4.3% | +79.9% |
| 5 y | 5 years | at high | +1692.7% | -4.3% | +732.6% |
| alltime | all time | at high | +1692.7% | -4.3% | +732.6% |
Monte Rosa Therapeutics Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $35.74 M(-4.3%) |
| June 2024 | - | $37.34 M(+3.7%) |
| Mar 2024 | - | $36.01 M(+3.3%) |
| Dec 2023 | $143.31 M(+27.5%) | $34.86 M(-5.7%) |
| Sept 2023 | - | $36.97 M(-0.7%) |
| June 2023 | - | $37.22 M(+8.6%) |
| Mar 2023 | - | $34.26 M(+5.4%) |
| Dec 2022 | $112.38 M | $32.49 M(+14.6%) |
| Sept 2022 | - | $28.36 M(+4.2%) |
| June 2022 | - | $27.23 M(+12.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $24.30 M(+3.9%) |
| Dec 2021 | $72.88 M(+160.2%) | $23.39 M(+17.7%) |
| Sept 2021 | - | $19.87 M(+9.6%) |
| June 2021 | - | $18.12 M(+57.5%) |
| Mar 2021 | - | $11.50 M(-3.6%) |
| Dec 2020 | $28.01 M(+250.4%) | $11.94 M(+86.9%) |
| Sept 2020 | - | $6.39 M(+18.3%) |
| June 2020 | - | $5.40 M(+25.7%) |
| Mar 2020 | - | $4.29 M |
| Dec 2019 | $7.99 M | - |
FAQ
- What is Monte Rosa Therapeutics annual total expenses?
- What is the all time high annual total expenses for Monte Rosa Therapeutics?
- What is Monte Rosa Therapeutics annual total expenses year-on-year change?
- What is Monte Rosa Therapeutics quarterly total expenses?
- What is the all time high quarterly total expenses for Monte Rosa Therapeutics?
- What is Monte Rosa Therapeutics quarterly total expenses year-on-year change?
What is Monte Rosa Therapeutics annual total expenses?
The current annual total expenses of GLUE is $143.31 M
What is the all time high annual total expenses for Monte Rosa Therapeutics?
Monte Rosa Therapeutics all-time high annual total expenses is $143.31 M
What is Monte Rosa Therapeutics annual total expenses year-on-year change?
Over the past year, GLUE annual total expenses has changed by +$30.93 M (+27.52%)
What is Monte Rosa Therapeutics quarterly total expenses?
The current quarterly total expenses of GLUE is $35.74 M
What is the all time high quarterly total expenses for Monte Rosa Therapeutics?
Monte Rosa Therapeutics all-time high quarterly total expenses is $37.34 M
What is Monte Rosa Therapeutics quarterly total expenses year-on-year change?
Over the past year, GLUE quarterly total expenses has changed by -$1.22 M (-3.31%)